ACADIA Pharmaceuticals’ (ACAD) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $27.00 price target on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for ACADIA Pharmaceuticals’ Q1 2025 earnings at $0.10 EPS, Q2 2025 earnings at $0.16 […]
HC Wainwright reiterated their buy rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $27.00 price target on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for ACADIA Pharmaceuticals’ Q1 2025 earnings at $0.10 EPS, Q2 2025 earnings at $0.16 […]
